Dr Tan is an experienced researcher in biomedical science with diverse experiences in molecular neurobiology, pharmacology and plant genetics engineering. He has obtained his MSc. in plant genetics engineering and Ph.D in neurobiology and pharmacology from National University of Singapore.
His main research interest is on pain peptides, pain biomarkers and looking into the epigenetics of pain in cancer treatments. Besides these, he is also interested in other research areas related to neurodegenerative diseases, brain cell therapy and brain imaging. Besides handling both local and international collaborative research projects, Dr Tan had also mentored more than 20 undergraduate, honours and postgraduate students; and research assistants.
1. C.Y. Ng, S. Kannan, Y.J. Chen, F.C.K. Tan, W.Y. Ong, M.L. Go, C.S. Verma, C.M. Low, Y. Lam (2017). A new generation of arachidonic acid analogues as potential neurological agent targeting cytosolic phospholipase A2. Sci. Rep. 7:13683.
2. C.Y. Ng, T.X.W. Kwok, F.C.K. Tan, C.M. Low, Y. Lam (2017) Fluorogenic probes to monitor cytosolic phospholipase A2 activity. Chem. Comm. 53: 1813-1816.
3. T. Jayakody, S. Marwari, R. Lakshminarayanan, F.C.K. Tan, C.W. Johannes, B.W. Dymock, A. Poulsen, D.R. Herr, G.S. Dawe (2016) Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity. Peptides, 84: 44-57.
4. K.S. Wee, F.C.K. Tan, Y.P. Cheong, S. Khanna, C.M. Low (2016) Ontogenic Profile and Synaptic Distribution of GluN3 Proteins in the Rat Brain and Hippocampal Neurons. Neurochem. Res. 41: 290-297.
5. C. Liu, F.C.K. Tan, Z.C. Xiao, G.S. Dawe (2015) Amyloid precursor protein enhances Nav1.6 sodium channel cell surface expression. J. Biol. Chem. 290(19): 12048-12057.
